Delivery Order SPE2DR25D1053-SPE2DR26FT840
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Adderall 5 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,266.02 and an ultimate completion date of September 4, 2025. The contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Adderall 5 mg tablets (100-count units) with a ceiling value of $6,330.10. This firm fixed-price contract, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a competitively awarded, non-set-aside procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and serves as a child order under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Adderall 15 mg tablets in quantities of 100 units, with a ceiling value of $5,396.89. This non-set-aside, competitively awarded delivery order represents a firm fixed-price contract with an ultimate completion date of June 10, 2025. The award supports federal medical procurement needs through AmerisourceBergen's extensive pharmaceutical distribution network, with performance...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (quantity 100s) with a ceiling value of $1,266.02. The contract is firm fixed price with an ultimate completion date of September 11, 2025, and was awarded on September 10, 2025. This award carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a delivery order valued at $1,793.21 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) with a firm fixed price and a completion deadline of August 26, 2025. This non-set-aside, competitively awarded contract represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which carries a $999.999 billion potential value through...
- The Defense Logistics Agency awarded a delivery order valued at $7,596.12 to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Adderall 20 mg tablets (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,532.04 to AmerisourceBergen Drug Corp for 100 tablets of Adderall 5 mg, with an ultimate completion date of September 8, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The performance location is the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,266.02 for 100 tablets of Adderall 15 mg, with a completion date of September 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order executed under AmerisourceBergen's larger pharmaceutical supply framework with the...
- The Defense Logistics Agency awarded a delivery order valued at $1,266.02 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) on June 2, 2025, with a completion date of June 3, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a $1,899.03 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Adderall 5 mg tablets (100-count units). This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by July 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT840Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Adderall 5 mg tablets (100-count units) with a ceiling value of $1,225.66. This non-set-aside, competitively awarded delivery order reflects a firm fixed-price contract type with an ultimate completion date of November 14, 2025. The award was issued on November 13, 2025, and represents a specific fulfillment request under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen serves as a critical vendor for military and federal healthcare systems, supplying a comprehensive range of medications and medical supplies. The company's federal contract portfolio demonstrates consistent capability in fulfilling competitive procurement requirements across multiple therapeutic domains, with delivery orders typically structured as firm fixed-price arrangements supporting the Defense Health Agency and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/13/25 |